Japanese Encephalitis Vaccine (JEV)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2DP-26-R-0001
NAICS
325414 - Biological Product (except Diagnostic) Manufacturing
Classification Code
6505
Additional Details
Documents2
The Defense Logistics Agency (DLA) Troop Support has announced a presolicitation for the procurement of the Japanese Encephalitis Virus Vaccine (JEV), specifically a purified, inactivated, single-dose prefilled syringe. This initiative is intended to ensure the reliable supply of JEV for military and related federal needs, supporting the health and readiness of personnel potentially exposed to the Japanese Encephalitis Virus.
The scope of this procurement encompasses the delivery of JEV manufactured in accordance with MPID Number 5, dated July 23, 2024. The vaccine must be FDA-approved for sale prior to the solicitation’s closing date, underscoring the agency’s commitment to safety and regulatory compliance. The contract will be structured as a firm-fixed price, indefinite delivery, indefinite quantity (IDIQ) agreement, with an eighteen-month base term. Quantities are defined as follows: a minimum of 277,760 units, an estimated quantity of 277,760 units, and a maximum of 394,240 units. Inspection and acceptance will occur at the destination, with delivery required to DLA Distribution Susquehanna, located at U Avenue, Building 89, Door 6, New Cumberland, PA 17070. The production lead time is set at 120 days following the issuance of each delivery order (DD1155).
The procurement is classified under NAICS code 325414 (Biological Product [except Diagnostic] Manufacturing), with product service code 6505. There are no set-aside requirements for this solicitation, making it open to all responsible sources capable of meeting the stated requirements. The solicitation will be issued under the authority of 10 U.S.C. § 3204(a)(1), as implemented by FAR 6.302-1, indicating that only one responsible source and no other supplies or services will satisfy agency requirements. FAR Part 12 procedures will be used, reflecting the agency’s intent to acquire commercial items.
Interested parties should note that solicitations and amendments will not be issued in paper form. All documentation and notifications will be available electronically via the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Offerors are encouraged to register for automated notifications and to monitor the DIBBS site for updates and amendments.
The contracting office is located at DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA 19111-5092. Key points of contact for this procurement are Alec Deichman (Contracting Specialist, 445-737-5743, [email protected]) and Jessica De La Hoz (Contracting Officer, 445-737-3623, [email protected]). The place of performance is Philadelphia, Pennsylvania.
This opportunity is active, with a response deadline of May 29, 2026. Contractors with FDA-approved JEV products and the capacity to meet the specified production and delivery requirements are encouraged to review the solicitation details and consider submitting a proposal. The contract’s terms, quantities, and regulatory requirements are expected to remain constant throughout its lifecycle, providing a stable framework for performance and compliance.